Successful Treatment of Chronic Eosinophilic Pneumonia with Anti-IgE Therapy
Journal of Korean Medical Science
;
: 1261-1264, 2012.
Artículo
en Inglés
| WPRIM
| ID: wpr-164984
ABSTRACT
Anti-IgE therapy, using recombinant humanized anti-IgE antibodies, is clinically effective in patients with eosinophil-related disorders such as allergic asthma, allergic rhinitis, and chronic urticaria. Chronic eosinophilic pneumonia tends to respond promptly to systemic corticosteroid therapy, however; relapses are common following corticosteroid tapering. We treated two patients (17- and 19-yr-old males) of chronic eosinophilic pneumonia whose symptoms were cough and dyspnea on exertion. The symptoms were recurrent while tapering off corticosteroid. They were treated with anti-IgE antibody without recurrence for 2 yr and 15 months. Here, we first describe clinical experience of the 2 cases of chronic eosinophilic pneumonia.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Eosinofilia Pulmonar
/
Tomografía Computarizada por Rayos X
/
Anticuerpos Antiidiotipos
/
Corticoesteroides
/
Tos
/
Disnea
Límite:
Adolescente
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Journal of Korean Medical Science
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS